Home › Funds › Integral Health Asset Management, LLC › CYTK
Integral Health Asset Management, LLC position in CYTK
CYTOKINETICS INC · Health Care
Integral Health Asset Management, LLC reported holding 1,600,000 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$72.5M, representing 4.70% of its reported portfolio and ranking #3 among its reported holdings. Integral Health Asset Management, LLC has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Integral Health Asset Management, LLC's CYTK position evolved
Integral Health Asset Management, LLC first disclosed a stake in CYTK in Q3 2023 at 800,000 shares (US$23.6M). The position peaked in Q2 2026 at 1,600,000 shares, worth US$136.3M. Across 13 filings, Integral Health Asset Management, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,600,000 shares valued at US$72.5M. Notable position changes include a 350% increase in Q1 2024 (shares fell 23% over the following quarter), a 122% increase in Q2 2024 (shares fell 3% over the following quarter), a 100% increase in Q1 2026 (shares rose 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 800.00K | $23.57M | New |
| Q4 2023 | 100.00K | $8.35M | Reduce |
| Q1 2024 | 450.00K | $31.55M | Add |
| Q2 2024 | 1.00M | $54.18M | Add |
| Q3 2024 | 750.00K | $39.60M | Reduce |
| Q4 2024 | 1.00M | $47.04M | Add |
| Q1 2025 | 1.10M | $44.21M | Add |
| Q2 2025 | 500.00K | $16.52M | Reduce |
| Q3 2025 | 750.00K | $41.22M | Add |
| Q4 2025 | 500.00K | $31.77M | Reduce |
| Q1 2026 | 1.00M | $65.91M | Add |
| Q2 2026 | 1.60M | $136.30M | Add |
| Q3 2026 | 1.60M | $72.50M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYTK and 13F data
CYTK (CYTOKINETICS INC) is a Health Care company. 39 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$323.0M), Polar Capital Holdings Plc (US$227.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYTK
- T. Rowe Price Investment Management, Inc. 18.72M sh · $1.59B · Q2 2026
- Avoro Capital Advisors LLC 4.90M sh · $322.96M · Q3 2026
- Polar Capital Holdings Plc 9.64M sh · $227.69M · Q3 2026
- RTW INVESTMENTS, LP 2.86M sh · $188.63M · Q3 2026
- Frazier Life Sciences Management, L.P. 1.16M sh · $98.81M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.18M sh · $77.79M · Q3 2026
- GW&K Investment Management, LLC 1.02M sh · $67.08M · Q3 2026
- Royalty Pharma Sub-Manager, LLC 980.39K sh · $64.62M · Q3 2026
- Foresite Capital Management IV, LLC 714.70K sh · $60.88M · Q2 2026
- Melqart Asset Management (UK) Ltd 761.54K sh · $50.19M · Q3 2026
- Affinity Asset Advisors, LLC 750.00K sh · $49.43M · Q3 2026
More on Integral Health Asset Management, LLC
FAQ
How long has Integral Health Asset Management, LLC held CYTK?
Integral Health Asset Management, LLC has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Integral Health Asset Management, LLC's current position in CYTK?
As of Q3 2026, Integral Health Asset Management, LLC holds 1.60M shares of CYTK (CYTOKINETICS INC), valued at $72.50M, representing 4.70% of its reported portfolio and ranking #3.
Has Integral Health Asset Management, LLC been buying or selling CYTK?
In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC held unchanged its position in CYTK. The position peaked in Q2 2026 at 1.60M shares.
Which other funds hold CYTK?
Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, Polar Capital Holdings Plc, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.